USANA Historical Income Statement

USNA Stock

USD 27.78 0.38 1.35%

Historical analysis of USANA Health income statement accounts such as Interest Expense of 177 K, Total Revenue of 597.3 M, Gross Profit of 485 M or Operating Income of 81.1 M can show how well USANA Health Sciences performed in making a profits. Evaluating USANA Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of USANA Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining USANA Health Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether USANA Health Sciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About USANA Income Statement Analysis

USANA Health Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to USANA Health shareholders. The income statement also shows USANA investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

USANA Health Income Statement Chart

At present, USANA Health's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 81 M, whereas Interest Expense is forecasted to decline to about 177 K.

Total Revenue Gross Profit Operating Income Ebitda

Total Revenue

Total revenue comprises all receipts USANA Health Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of USANA Health Sciences minus its cost of goods sold. It is profit before USANA Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Operating Income

Operating Income is the amount of profit realized from USANA Health Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of USANA Health Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from USANA Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into USANA Health Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Gross Profit	804.7M	744.3M	693.3M	485.0M
Total Revenue	998.6M	921.0M	854.5M	597.3M

Gross Profit Total Revenue

USANA Health income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Operating Income	Ebit	Ebitda	Net Income	Income Tax Expense	Depreciation And Amortization	Other Operating Expenses	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Selling General Administrative	Net Income From Continuing Ops	Non Operating Income Net Other	Selling And Marketing Expenses	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.35	0.33	0.19	0.22	0.27	0.26	0.08	0.48	0.37	0.53	0.41	0.36	0.21	0.27	0.18	0.19	-0.02	0.38	-0.4	0.3	0.27	0.43	0.24
Total Revenue	0.35		1.0	0.89	0.91	0.95	0.85	0.9	0.69	1.0	0.64	0.99	1.0	0.92	0.05	0.59	0.68	0.51	0.78	0.3	0.07	0.06	0.35	-0.11
Gross Profit	0.33	1.0		0.9	0.92	0.95	0.86	0.91	0.68	0.99	0.63	0.99	1.0	0.92	0.04	0.59	0.69	0.52	0.78	0.32	0.05	0.05	0.33	-0.12
Operating Income	0.19	0.89	0.9		1.0	0.98	0.98	0.87	0.44	0.85	0.36	0.85	0.85	1.0	-0.23	0.42	0.89	0.53	0.71	0.5	-0.21	-0.22	0.13	-0.36
Ebit	0.22	0.91	0.92	1.0		0.99	0.97	0.88	0.48	0.88	0.4	0.87	0.88	1.0	-0.17	0.4	0.88	0.53	0.73	0.47	-0.16	-0.16	0.17	-0.31
Ebitda	0.27	0.95	0.95	0.98	0.99		0.96	0.89	0.56	0.92	0.48	0.92	0.92	0.99	-0.1	0.45	0.85	0.55	0.76	0.43	-0.09	-0.09	0.26	-0.26
Net Income	0.26	0.85	0.86	0.98	0.97	0.96		0.76	0.44	0.81	0.35	0.82	0.81	0.97	-0.22	0.39	0.92	0.47	0.66	0.35	-0.19	-0.2	0.19	-0.34
Income Tax Expense	0.08	0.9	0.91	0.87	0.88	0.89	0.76		0.51	0.88	0.45	0.85	0.89	0.89	-0.03	0.49	0.61	0.6	0.72	0.64	-0.05	-0.05	0.12	-0.2
Depreciation And Amortization	0.48	0.69	0.68	0.44	0.48	0.56	0.44	0.51		0.73	0.97	0.75	0.72	0.49	0.61	0.54	0.22	0.44	0.77	-0.1	0.66	0.65	0.87	0.38
Other Operating Expenses	0.37	1.0	0.99	0.85	0.88	0.92	0.81	0.88	0.73		0.68	0.99	1.0	0.88	0.1	0.6	0.63	0.49	0.79	0.26	0.12	0.12	0.39	-0.06
Research Development	0.53	0.64	0.63	0.36	0.4	0.48	0.35	0.45	0.97	0.68		0.71	0.68	0.41	0.69	0.49	0.1	0.3	0.75	-0.21	0.75	0.74	0.81	0.5
Cost Of Revenue	0.41	0.99	0.99	0.85	0.87	0.92	0.82	0.85	0.75	0.99	0.71		0.99	0.87	0.1	0.59	0.64	0.45	0.79	0.2	0.13	0.13	0.44	-0.07
Total Operating Expenses	0.36	1.0	1.0	0.85	0.88	0.92	0.81	0.89	0.72	1.0	0.68	0.99		0.88	0.1	0.61	0.63	0.5	0.79	0.27	0.12	0.11	0.38	-0.06
Income Before Tax	0.21	0.92	0.92	1.0	1.0	0.99	0.97	0.89	0.49	0.88	0.41	0.87	0.88		-0.16	0.44	0.87	0.55	0.73	0.48	-0.15	-0.16	0.18	-0.31
Total Other Income Expense Net	0.27	0.05	0.04	-0.23	-0.17	-0.1	-0.22	-0.03	0.61	0.1	0.69	0.1	0.1	-0.16		0.18	-0.41	0.16	0.27	-0.37	0.97	0.97	0.61	0.73
Selling General Administrative	0.18	0.59	0.59	0.42	0.4	0.45	0.39	0.49	0.54	0.6	0.49	0.59	0.61	0.44	0.18		0.16	0.29	0.39	0.1	0.19	0.19	0.3	0.07
Net Income From Continuing Ops	0.19	0.68	0.69	0.89	0.88	0.85	0.92	0.61	0.22	0.63	0.1	0.64	0.63	0.87	-0.41	0.16		0.49	0.57	0.43	-0.39	-0.4	0.07	-0.49
Non Operating Income Net Other	-0.02	0.51	0.52	0.53	0.53	0.55	0.47	0.6	0.44	0.49	0.3	0.45	0.5	0.55	0.16	0.29	0.49		0.58	0.53	0.11	0.11	0.3	-0.12
Selling And Marketing Expenses	0.38	0.78	0.78	0.71	0.73	0.76	0.66	0.72	0.77	0.79	0.75	0.79	0.79	0.73	0.27	0.39	0.57	0.58		0.3	0.33	0.32	0.53	0.14
Tax Provision	-0.4	0.3	0.32	0.5	0.47	0.43	0.35	0.64	-0.1	0.26	-0.21	0.2	0.27	0.48	-0.37	0.1	0.43	0.53	0.3		-0.43	-0.41	-0.32	-0.46
Interest Income	0.3	0.07	0.05	-0.21	-0.16	-0.09	-0.19	-0.05	0.66	0.12	0.75	0.13	0.12	-0.15	0.97	0.19	-0.39	0.11	0.33	-0.43		1.0	0.68	0.8
Net Interest Income	0.27	0.06	0.05	-0.22	-0.16	-0.09	-0.2	-0.05	0.65	0.12	0.74	0.13	0.11	-0.16	0.97	0.19	-0.4	0.11	0.32	-0.41	1.0		0.67	0.8
Reconciled Depreciation	0.43	0.35	0.33	0.13	0.17	0.26	0.19	0.12	0.87	0.39	0.81	0.44	0.38	0.18	0.61	0.3	0.07	0.3	0.53	-0.32	0.68	0.67		0.44
Extraordinary Items	0.24	-0.11	-0.12	-0.36	-0.31	-0.26	-0.34	-0.2	0.38	-0.06	0.5	-0.07	-0.06	-0.31	0.73	0.07	-0.49	-0.12	0.14	-0.46	0.8	0.8	0.44

Click cells to compare fundamentals

USANA Health Account Relationship Matchups

USANA Health income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	507K	57K	192K	262K	281K	177.0K
Total Revenue	1.1B	1.2B	998.6M	921.0M	854.5M	597.3M
Gross Profit	925.5M	968.6M	804.7M	744.3M	693.3M	485.0M
Operating Income	176.5M	170.2M	107.6M	93.1M	66.3M	81.1M
Ebit	176.5M	170.2M	107.6M	102.7M	76.6M	81.0M
Ebitda	199M	192.4M	129.0M	123.1M	98.9M	91.4M
Net Income	124.7M	116.5M	69.4M	63.8M	42.0M	53.3M
Income Tax Expense	53.3M	54.1M	39.3M	38.7M	34.3M	28.5M
Depreciation And Amortization	22.5M	22.2M	21.4M	20.4M	22.2M	23.3M
Other Operating Expenses	958.2M	1.0B	891.0M	827.9M	788.2M	533.5M
Research Development	10.6M	11.1M	11.6M	11.4M	13.2M	13.8M
Cost Of Revenue	209.1M	217.9M	193.9M	176.7M	161.2M	116.1M
Total Operating Expenses	749.0M	798.4M	697.1M	651.2M	627.0M	417.4M
Income Before Tax	177.9M	170.6M	108.6M	102.5M	76.4M	84.6M
Total Other Income Expense Net	1.5M	450K	1.0M	9.4M	10.0M	10.5M
Selling General Administrative	261.2M	279.1M	262.3M	257.0M	263.3M	223.2M
Net Income Applicable To Common Shares	100.5M	124.7M	116.5M	69.4M	79.8M	65.4M
Net Income From Continuing Ops	124.7M	116.5M	69.4M	59.8M	42.1M	40.0M
Non Operating Income Net Other	3.2M	4.4M	2.0M	507K	583.1K	553.9K
Selling And Marketing Expenses	487.9M	519.3M	434.8M	370.1M	425.6M	464.3M
Tax Provision	53.3M	54.1M	39.3M	38.8M	34.3M	39.5M
Interest Income	2.5M	2.5M	3.8M	8.2M	11.3M	11.9M
Net Interest Income	2.0M	2.5M	3.6M	8.0M	11.0M	11.6M
Reconciled Depreciation	22.5M	22.2M	21.4M	20.8M	22.2M	22.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:

How To Invest In USANA

Details

Is USANA Stock a good investment?

Details

What is USANA Health's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.74)

Earnings Share

2.19

Revenue Per Share

44.731

Quarterly Revenue Growth

(0.03)

Return On Assets

0.06

The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

USANA Historical Income Statement

About USANA Income Statement Analysis

USANA Health Income Statement Chart

Total Revenue

Gross Profit

Operating Income

USANA Health income statement Correlations

USANA Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

USANA Health income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Gross Profit
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income

Extraordinary Items	- 0.49	Net Income From Continuing Ops
Extraordinary Items	- 0.46	Tax Provision
Interest Income	- 0.43	Tax Provision
Net Interest Income	- 0.41	Tax Provision
Net Income From Continuing Ops	- 0.41	Total Other Income Expense Net
Net Interest Income	- 0.4	Net Income From Continuing Ops